ABNB
Airbnb, Inc.
ABNB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN
Amazon.com, Inc.
AMZN has the edge over ABNB overall, supported by stronger valuation and stronger modeled upside.
ABNB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Unavailable |
ABNB's revenue, profitability and cash flow are currently healthy. There isn't enough data to rate its balance sheet.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ABNB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $108 | -41% |
| Forward | 29x | $181 | — |
| Fair | 34x | $183 | +1.3% |
| Current | 34x | $181 | — |
| Expensive | 46x | $245 | +35% |
Historical ranges are pointers, not guarantees.
ABNB's PE is in its fair range at 34x. If earnings grow as analysts expect, today's price would be 29x next year's earnings, in its cheap range.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ABNB in the historical PE scenario, which offers more potential upside but is not a forecast.
ABNB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
ABNB has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ABNB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.18 | +16% |
| Q3 2026 | $5.34 | +27% |
| Q2 2026 | $4.39 | +6.8% |
| Q1 2026 | $4.05 | +2.8% |
| Q4 2025 | $4.03 | -1.9% |
| Q3 2025 | $4.19 | +47% |
| Q2 2025 | $4.11 | -44% |
| Q1 2025 | $3.94 | -47% |
| Q4 2024 | $4.11 | -43% |
ABNB's earnings per share have fallen from their peak: $5.34 over the past year, against $8.26 in late 2023.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ABNB on earnings, with more consistent year-over-year improvement.
ABNB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.9B | +19% |
| Q2 2026 | $3.6B | +17% |
| Q1 2026 | $2.7B | +18% |
| Q4 2025 | $2.8B | +12% |
| Q3 2025 | $4.1B | +9.7% |
| Q2 2025 | $3.1B | +13% |
| Q1 2025 | $2.3B | +6.1% |
| Q4 2024 | $2.5B | +12% |
ABNB's revenue has grown year over year for 23 quarters in a row: $4.9B last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 42% | +1.8 points |
| Q2 2026 | 21% | +1.2 points |
| Q1 2026 | 3.2% | +1.5 points |
| Q4 2025 | 9.7% | -7.7 points |
| Q3 2025 | 40% | -1.2 points |
| Q2 2025 | 20% | +1.7 points |
| Q1 2025 | 1.7% | -3 points |
| Q4 2024 | 17% | +40 points |
ABNB has the edge over AMZN on profitability, with a higher operating margin.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ABNB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
ABNB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +11% |
| Q2 2026 | $1.3B | +30% |
| Q1 2026 | $1.7B | -4.5% |
| Q4 2025 | $526M | +13% |
| Q3 2025 | $1.4B | +26% |
| Q2 2025 | $975M | -7.2% |
| Q1 2025 | $1.8B | -7% |
| Q4 2024 | $466M | +640% |
ABNB has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ABNB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -3.9% | -24M shares |
| 3 years | -9.5% | -63M shares |
| 5 years | -12% | -84.9M shares |
| Available history | +12% | +66.1M shares |
ABNB has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $712M |
| Q2 2026 | $1.1B |
| Q1 2026 | $1.1B |
| Q4 2025 | $1.1B |
| Q3 2025 | $877M |
| Q2 2025 | $1B |
| Q1 2025 | $807M |
| Q4 2024 | $838M |
ABNB spent $3.9B buying back its own shares over the past year, up 12% from the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ABNB Net Leverage
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ABNB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 66.8 | Neutral |
ABNB's weekly RSI is 60 (neutral) and its Stochastic is 67 (neutral).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ABNB PE vs Consumer Cyclical Sector
| Metric | ABNB | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 18x | 88% above |
| PE % | 48 | 50 | 2 pts below |
ABNB is trading at 34x earnings, a 88% premium to the Consumer Cyclical sector's median of 18x.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over ABNB on valuation relative to its sector.
ABNB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $170.9 | 6% above |
| 20 week MA | $168.0 | 7.8% above |
| 50 week MA | $146.8 | 23% above |
| 100 week MA | $137.8 | 31% above |
| 200 week MA | $135.9 | 33% above |
ABNB is in an uptrend: it's above all five of its weekly moving averages, and 33% above its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ABNB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.3 | $154.8 | +11% |
| 2021 | $154.8 | $171.3 | +11% |
| 2022 | $171.3 | $85.3 | -50% |
| 2023 | $85.3 | $136.1 | +60% |
| 2024 | $136.1 | $133.4 | -2% |
| 2025 | $133.4 | $136.8 | +2.6% |
| 2026 YTD | $136.8 | $181.1 | +32% |
ABNB has the edge over AMZN on returns for 2026, with the stronger performance.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.